Guggenheim raised the firm’s price target on Itron (ITRI) to $155 from $133 and keeps a Buy rating on the shares. Despite a continuing positive stance, the firm no longer sees upside sufficient to merit keeping Itron as a Best Idea, and is removing the Best Idea designation for the company, the analyst tells investors in a research note. Guggenheim expects more meaningful improvement in the Outcomes segment in 2026 and 2027.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ITRI:
- Itron has shipped more than 2M Cyble 5 communication module
- Itron signs contract with HEDNO to lay foundation for grid edge intelligence
- Itron price target raised to $145 from $139 at TD Cowen
- Itron exec Patrick sells 9,036 common shares
- Itron’s Strategic Advantage in Grid Modernization and Market Consolidation